202 related articles for article (PubMed ID: 23733388)
1. Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography.
Baiocco P; Poce G; Alfonso S; Cocozza M; Porretta GC; Colotti G; Biava M; Moraca F; Botta M; Yardley V; Fiorillo A; Lantella A; Malatesta F; Ilari A
ChemMedChem; 2013 Jul; 8(7):1175-83. PubMed ID: 23733388
[TBL] [Abstract][Full Text] [Related]
2. Metal-based compounds as prospective antileishmanial agents: inhibition of trypanothione reductase by selected gold complexes.
Colotti G; Ilari A; Fiorillo A; Baiocco P; Cinellu MA; Maiore L; Scaletti F; Gabbiani C; Messori L
ChemMedChem; 2013 Oct; 8(10):1634-7. PubMed ID: 24039168
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives.
Saccoliti F; Angiulli G; Pupo G; Pescatori L; Madia VN; Messore A; Colotti G; Fiorillo A; Scipione L; Gramiccia M; Di Muccio T; Di Santo R; Costi R; Ilari A
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):304-310. PubMed ID: 28098499
[TBL] [Abstract][Full Text] [Related]
4. Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism.
Colotti G; Saccoliti F; Gramiccia M; Di Muccio T; Prakash J; Yadav S; Dubey VK; Vistoli G; Battista T; Mocci S; Fiorillo A; Bibi A; Madia VN; Messore A; Costi R; Di Santo R; Ilari A
Amino Acids; 2020 Feb; 52(2):247-259. PubMed ID: 31037461
[TBL] [Abstract][Full Text] [Related]
5. First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity
Ruiz-Santaquiteria M; Sánchez-Murcia PA; Toro MA; de Lucio H; Gutiérrez KJ; de Castro S; Carneiro FAC; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
Eur J Med Chem; 2017 Jul; 135():49-59. PubMed ID: 28431354
[TBL] [Abstract][Full Text] [Related]
6. A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition.
Ilari A; Baiocco P; Messori L; Fiorillo A; Boffi A; Gramiccia M; Di Muccio T; Colotti G
Amino Acids; 2012 Feb; 42(2-3):803-11. PubMed ID: 21833767
[TBL] [Abstract][Full Text] [Related]
7. Pyridazino-pyrrolo-quinoxalinium salts as highly potent and selective leishmanicidal agents targeting trypanothione reductase.
de Lucio H; García-Marín J; Sánchez-Alonso P; García-Soriano JC; Toro MÁ; Vaquero JJ; Gago F; Alajarín R; Jiménez-Ruiz A
Eur J Med Chem; 2022 Jan; 227():113915. PubMed ID: 34695777
[TBL] [Abstract][Full Text] [Related]
8. Molecular docking studies of selected tricyclic and quinone derivatives on trypanothione reductase of Leishmania infantum.
Venkatesan SK; Shukla AK; Dubey VK
J Comput Chem; 2010 Oct; 31(13):2463-75. PubMed ID: 20340105
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of phenothiazine- and phenoxazine-derived chloroacetamides on Leishmania major growth and Trypanosoma brucei trypanothione reductase.
Marcu A; Schurigt U; Müller K; Moll H; Krauth-Siegel RL; Prinz H
Eur J Med Chem; 2016 Jan; 108():436-443. PubMed ID: 26708110
[TBL] [Abstract][Full Text] [Related]
11. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
[TBL] [Abstract][Full Text] [Related]
12. Novel Heteroaryl Selenocyanates and Diselenides as Potent Antileishmanial Agents.
Baquedano Y; Alcolea V; Toro MÁ; Gutiérrez KJ; Nguewa P; Font M; Moreno E; Espuelas S; Jiménez-Ruiz A; Palop JA; Plano D; Sanmartín C
Antimicrob Agents Chemother; 2016 Jun; 60(6):3802-12. PubMed ID: 27067328
[TBL] [Abstract][Full Text] [Related]
13. Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening.
Turcano L; Torrente E; Missineo A; Andreini M; Gramiccia M; Di Muccio T; Genovese I; Fiorillo A; Harper S; Bresciani A; Colotti G; Ilari A
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006969. PubMed ID: 30475811
[TBL] [Abstract][Full Text] [Related]
14. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
[TBL] [Abstract][Full Text] [Related]
15. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
[TBL] [Abstract][Full Text] [Related]
16. Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase.
Persch E; Bryson S; Todoroff NK; Eberle C; Thelemann J; Dirdjaja N; Kaiser M; Weber M; Derbani H; Brun R; Schneider G; Pai EF; Krauth-Siegel RL; Diederich F
ChemMedChem; 2014 Aug; 9(8):1880-91. PubMed ID: 24788386
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
Khabnadideh S; Pez D; Musso A; Brun R; Pérez LM; González-Pacanowska D; Gilbert IH
Bioorg Med Chem; 2005 Apr; 13(7):2637-49. PubMed ID: 15755663
[TBL] [Abstract][Full Text] [Related]
18. Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme.
Turcano L; Battista T; De Haro ET; Missineo A; Alli C; Paonessa G; Colotti G; Harper S; Fiorillo A; Ilari A; Bresciani A
PLoS Negl Trop Dis; 2020 May; 14(5):e0008339. PubMed ID: 32437349
[TBL] [Abstract][Full Text] [Related]
19. Diaryl sulfide-based inhibitors of trypanothione reductase: inhibition potency, revised binding mode and antiprotozoal activities.
Stump B; Eberle C; Kaiser M; Brun R; Krauth-Siegel RL; Diederich F
Org Biomol Chem; 2008 Nov; 6(21):3935-47. PubMed ID: 18931800
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of
Madia VN; Ialongo D; Patacchini E; Exertier C; Antonelli L; Colotti G; Messore A; Tudino V; Saccoliti F; Scipione L; Ilari A; Costi R; Di Santo R
Molecules; 2023 Jan; 28(1):. PubMed ID: 36615531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
